MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma
Tetsu Tomonari(Tokushima University), Tetsuji Takayama(Tokushima University)
Cited by 66
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer
|International Journal of Clinical Oncology|2021|157
AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer
|JCI Insight|2018|148
EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer
|Molecular Cancer Research|2017|62
High antitumor activity of pladienolide B and its derivative in gastric cancer
|Cancer Science|2013|52